Activated Human CD4+ T Cells Induced by Dendritic Cell Stimulation Are Most Sensitive to Transforming Growth Factor-β: Implications for Dendritic Cell Immunization against Cancer

This publication has 44 references indexed in Scilit:

• Immunological Gene Therapy withex VivoGene-Modified Tumor Cells: A Critique and a Reappraisal
  Human Gene Therapy, 2000
• REGULATION OF IMMUNE RESPONSES BY TGF-β
  Annual Review of Immunology, 1998
• The host—tumor immune conflict: from immunosuppression to resistance and destruction
  Immunology Today, 1997
• Production of vascular endothelial growth factor by human tumors inhibits the functional maturation of dendritic cells
  Nature Medicine, 1996
• Upstream-Downstream: CD28 Cosignaling Pathways and T Cell Function
  Immunity, 1996
• Alterations in the signal‐transducing molecules of T cells and nk cells in colorectal tumor‐infiltrating, gut mucosal and peripheral lymphocytes: Correlation with the stage of the disease
  International Journal of Cancer, 1995
• Cancer antigens: immune recognition of self and altered self.
  The Journal of Experimental Medicine, 1994
• Anti-transforming growth factor (TGF)-beta antibodies inhibit breast cancer cell tumorigenicity and increase mouse spleen natural killer cell activity. Implications for a possible role of tumor cell/host TGF-beta interactions in human breast cancer progression.
  Journal of Clinical Investigation, 1993
• Memory T-lymphocytes are the main population of tumor-infiltrating lymphocytes obtained from human primary liver tumors
  Journal of Hepatology, 1992
• The Dendritic Cell System and its Role in Immunogenicity
  Annual Review of Immunology, 1991